bioAffinity Technologies, Inc. (BIAF)
6.055
-0.09
(-1.46%)
USD |
NASDAQ |
Oct 02, 16:00
6.06
0.00 (0.00%)
Pre-Market: 20:00
bioAffinity Technologies Enterprise Value : 1.743M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.743M |
| October 01, 2026 | 1.784M |
| September 30, 2026 | 1.972M |
| September 29, 2026 | 2.116M |
| September 28, 2026 | 2.356M |
| September 25, 2026 | 2.591M |
| September 24, 2026 | 2.546M |
| September 23, 2026 | 2.596M |
| September 22, 2026 | 2.874M |
| September 21, 2026 | 2.487M |
| September 18, 2026 | 3.270M |
| September 17, 2026 | 2.962M |
| September 16, 2026 | 1.425M |
| September 15, 2026 | 1.881M |
| September 14, 2026 | 2.591M |
| September 11, 2026 | 2.600M |
| September 10, 2026 | 3.252M |
| September 09, 2026 | 3.753M |
| September 08, 2026 | 3.043M |
| September 04, 2026 | 5.910M |
| September 03, 2026 | 4.784M |
| September 02, 2026 | 3.414M |
| September 01, 2026 | 1.985M |
| August 31, 2026 | 1.067M |
| August 28, 2026 | 1.208M |
| Date | Value |
|---|---|
| August 27, 2026 | 1.293M |
| August 26, 2026 | 1.307M |
| August 25, 2026 | 1.352M |
| August 24, 2026 | 1.637M |
| August 21, 2026 | 1.718M |
| August 20, 2026 | 1.719M |
| August 19, 2026 | 1.780M |
| August 18, 2026 | 2.216M |
| August 17, 2026 | 1.664M |
| August 14, 2026 | 1.733M |
| August 13, 2026 | 1.603M |
| August 12, 2026 | 2.212M |
| August 11, 2026 | 2.302M |
| August 10, 2026 | 2.329M |
| August 07, 2026 | 2.465M |
| August 06, 2026 | 2.598M |
| August 05, 2026 | 2.599M |
| August 04, 2026 | 2.739M |
| August 03, 2026 | 3.057M |
| July 31, 2026 | 3.261M |
| July 30, 2026 | 3.376M |
| July 29, 2026 | 2.973M |
| July 28, 2026 | 3.268M |
| July 27, 2026 | 3.629M |
| July 24, 2026 | 3.481M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Veracyte, Inc. | 3.236B |
| Quantum Cyber NV | 28.87M |
| MediciNova, Inc. | 62.31M |
| ADMA Biologics, Inc. | 2.258B |
| ACADIA Pharmaceuticals, Inc. | 2.551B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.366M |
| Revenue (Quarterly) | 1.511M |
| Total Expenses (Quarterly) | 4.877M |
| EPS Diluted (Quarterly) | -9.660 |
| Gross Profit Margin (Quarterly) | 23.91% |
| Profit Margin (Quarterly) | -222.8% |
| Earnings Yield | -1.71K% |
| Normalized Earnings Yield | -1259.06 |